Trailing-twelve-month (TTM) revenue is $96.01 Million with a year-over-year growth of (24.69%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q1 FY2026Period ended 2025-09-30 | $30,350,884 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q2 FY2026Period ended 2025-12-31 | $20,286,556 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-06 |
| Q3 FY2026Period ended 2026-03-31 | $18,685,501 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q4 FY2026Period ended 2026-06-30 | $26,691,669 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-09-15 |
| TTM revenue | $96,014,610 |
Current P/S: $75,193,207 market capitalization ÷ $96,014,610 TTM revenue = 0.78x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:35:50.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q4 FY2026 (2026-06-30): $26.69M.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 16 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:42:24.704Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-06-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-06-30 · USD | FY20252025-06-30 · USD | FY20262026-06-30 · USD |
|---|---|---|---|
| Asia Pacific | $18M | $12M | $11M |
| Europe | $65M | $74M | $61M |
| North America | $63M | $33M | $15M |
$96.01M
$96.01 Million
(24.69%)
vs. $127.49M a year ago (TTM)
+8.65%
5 Year compound annual growth rate
1 Year
(24.69%)
3 Year
(6.00%)
5 Year
+8.65%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $96.01M | ($31.48M) | (24.69%) |
| 2025 | $127.49M | ($24.41M) | (16.07%) |
| 2024 | $151.91M | +$36.30M | +31.40% |
| 2023 | $115.61M | +$27.51M | +31.23% |
| 2022 | $88.10M | +$24.68M | +38.92% |
TTM Growth
(24.69%)
3-Year CAGR
(6.00%)
5-Year CAGR
+8.65%
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T14:42:24.704Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-15.
